Home

Drug induced hepatitis treatment guidelines

Drug-Induced Hepatitis Johns Hopkins Medicin

  1. s, herbal remedies, or food supplements. In most cases, you may be taking a medicine for several months before it reaches a toxic level and affects your liver
  2. Stop standard TB treatment, co-trimoxazole prophylaxis and all other hepatotoxic drugs. If the patient is on an NNRTI-based regimen, stop the NNRTI first and the NRTIs after 5 - 7 days. However, if the patient is in liver failure, stop all ART immediately. If the patient is on a PI-based regimen, stop all drugs at once
  3. Treatment of LTBI Treatment of TB Disease Priorities for Research of Hepatotoxicity in Treatment of LTBI and of TB Disease Conclusions Drug-induced liver injury (DILI) is a problem of increasing signifi-cance, but has been a long-standing concern in the treatment Am J Respir Crit Care Med Vol 174. pp 935-952, 2006 DOI: 10.1164/rccm.200510-1666S
  4. 1. Drugs used for therapeutic intent may cause serious or fatal liver injury in some patients - unpredictable, scary 2. Although rare, DILI may result in disapproval of a new drug
  5. ase and alanine transa
  6. Budesonide and AZA or predniso (lo)ne and AZA are recommended as first-line AIH treatments in children and adults who do not have cirrhosis, acute severe hepatitis, or ALF. AZA can be continued throughout pregnancy, whereas the use of MMF is contraindicated in pregnancy
  7. AASLD Guidelines for Treatment of Chronic Hepatitis B [Website View.] November 2015. AASLD Guidelines for Treatment of Chronic Hepatitis B(link is external) [Website View] Three systematic reviews that were commissioned to support the guideline were published in January 2016
An Update on Treatment of Drug-Induced Liver Injury[PDF] South African guideline for the management of

Idiosyncratic drug-induced liver injury (DILI) is a rare adverse drug reaction and it can lead to jaundice, liver failure, or even death. Antimicrobials and herbal and dietary supplements are among the most common therapeutic classes to cause DILI in the Western world 1 Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia Quentin A Hill1, Robert Stamps2, Edwin Massey3, John D Grainger4, Drew Provan5 and Anita Hill1 on behalf of the British Society for Haematology. 1Department of Haematology, Leeds Teaching Hospitals, 2NHSBT, Sheffield, 3NHSBT, Bristol, 4Royal Manchester Children's Hospital, University o People with severe symptoms are likely to receive supportive therapy in the hospital, including intravenous fluids and medication to relieve nausea and vomiting. Your doctor will also monitor for liver damage. Medication to reverse liver damage caused by acetaminophen

Drug Induced Liver Injury (DILI

The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center [corrected]. J Clin Gastroenterol 2005; 39:64. Goldberg DS, Forde KA, Carbonari DM, et al. Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system All expert recommendations include treatment cessation at ALT > 5xULN or if the patient is icteric; ATS recommends cessation if ALT is 3-5xULN and the patient reports symptoms including nausea, anorexia, vomiting, abdominal pain and jaundice Drug-induced hepatitis may occur with Octreotide used for the treatment of congenital hyperinsulinism in children. Children on long-term Octreotide should have liver function monitoring, in particular serum alanine transaminase (ALT) levels Drug-induced hepatotoxicity (DIH) is the most common adverse drug reaction leading to interruption of antituberculosis treatment. Worldwide, different reintroduction regimens have been advocated, but no consensus guidelines are available. Reintroduction of antituberculosis drugs in patients with DIH has never been studied systematically Treatment of TB in Patients With Drug-Induced Hepatitis - Medscape - Jun 09, 2010. Tables. Authors and Disclosures. Authors and Disclosures. Author (s) William R. Jarvis, MD. President, Jason and.

drug-induced liver injury (DILI), alcoholic or non-alcoholic steatohepatitis (NASH) or viral hepatitis. Each condition provides special diagnostic and therapeutic challenges. Despite these chal-lenges and complexities, diagnosis and treatment of AIH has seen striking progress, and now patients in specialised centres have a Treatment should be interrupted and, generally, a modified or alternative regimen used for those with ALT elevation more than three times the upper limit of normal (ULN) in the presence of hepatitis symptoms and/or jaundice, or five times the ULN in the absence of symptoms

Immune Checkpoint Inhibitors-Induced Hepatiti

The immunogenetics of antituberculosis drug-induced hepatotoxicity, especially inclusive of acetylaor phenotype polymorphism, have been increasingly unravelled. Other principal clinical risk factors for hepatotoxicity are old age, malnutrition, alcoholism, HIV infection, as well as chronic hepatitis B and C infections Guidelines for drug-induced liver injury were published in March 2019 by the European Association for the Study of the Liver. Diagnosis . Classify drug-induced liver injury (DILI) as hepatocellular, cholestatic, or mixed according to the pattern of elevation of liver enzymes based on the first set of lab tests available

The median interval from treatment initiation of drug to development of clinical symptoms is 16 weeks (range 6 weeks-6 months). 11-13 Anti-TB drug induced fulminant liver failure appears to have worse outcome when compared with that related to acute viral hepatitis with a case fatality rate between 0.042 and 0.07 per 1000 persons at any. 10. Kishore PV et.at.Drug induced hepatitis with anti-tubercular chemotherapy: Challenges and difficulties in treatment, Kathmandu University Medical Journal (2007), Vol. 5, No. 2, Issue 18, 256-60. Indian Journal of Pharmacy Practice Volume 6 Issue 2 Apr - Jun, 2013 67 Amer K - Anti-Tuberculosis Drug - Induced Hepatitis - A Case Repor

Diagnosis and Management of Autoimmune Hepatitis in Adults

In the United States, drug-induced liver injury (DILI) is the most common cause of acute liver failure. 1,2 It can occur due to ingestion of any therapeutic drug, herbal product, or xenobiotic. Further complicating matters is the fact that it has an unpredictable and heterogeneous course, ranging from an asymptomatic rise in liver enzymes to. Toxic hepatitis is an inflammation of your liver in reaction to certain substances to which you're exposed. Toxic hepatitis can be caused by alcohol, chemicals, drugs or nutritional supplements. In some cases, toxic hepatitis develops within hours or days of exposure to a toxin The use of corticosteroids should be limited to DILI in the setting of drug-induced AIH, immune therapy-related severe hepatitis, or in the presence of features of hypersensitivity. Corticosteroid treatment in one retrospective analysis was associated with lower survival in patients with more severe liver injury The only specific treatment for most cases of liver damage caused by taking a drug is to stop taking the drug that caused the problem. However, if you took high doses of acetaminophen, you should get treated for liver injury in the emergency department or other acute treatment setting as soon as possible.. If symptoms are severe, you should rest and avoid heavy exercise, alcohol, acetaminophen. In the case of confirmed moderate or severe drug-induced hepatotoxicity, treatment should be interrupted and reintroduced after the hepatotoxicity has resolved. There is no consensus on method of the reintroduction of anti-TB medications. The risk of reintroducing of a anti-TB medications could be hazardous

The most common cause is chronic alcohol abuse; however, other etiologies include infectious hepatitis, drug-induced liver disease, nonalcoholic liver disease, and metabolic disorders The goal of treatment for drug-induced hepatitis is to discontinue taking the causative agent and monitor the liver closely while it recovers. Some drugs may cause a slight increase in liver enzymes without symptoms. It may not be necessary to discontinue using these medications. Always consult your physician

Aasld Guidelines Hepatitis B 2018 Ppt

Practice Guidelines AASL

Drug-induced hepatitis is rare and is caused by toxic exposure to certain medications, vitamins, herbal remedies, or food supplements. Usually, the toxicity occurs after taking the causative agent for several months, or from an overdose of a medication such as acetaminophen. Usually, the agent is discontinued once hepatitis is suspected and is. The rates of drug-induced hepatitis from various TB chemoprophylaxis regimens have been given in earlier BTS guidelines.10 These were based on a database search (Medline and Embase) of the reported hepatotoxicity of antituberculosis chemoprophylaxis from 1966 to 2002 in adults

ACG Clinical Guideline: The Diagnosis and Management of

  1. Potential mechanisms of drug-induced liver injury. The normal hepatocyte may be affected adversely by drugs through (A) disruption of intracellular calcium homeostasis that leads to the disassembly of actin fibrils at the surface of the hepatocyte, resulting in blebbing of the cell membrane, rupture, and cell lysis; (B) disruption of actin filaments next to the canaliculus (the specialized.
  2. When suspected, evaluate drug-induced autoimmune hepatitis (AIH) in detail. This includes causality assessment, serology, genetic tests, and liver biopsy. A multidisciplinary team should make decisions regarding corticosteroid treatment of immune-mediated hepatitis associated with immune checkpoint inhibitors
  3. s, herbal and dietary supplements, and anticancer therapeutics (e.g., tyrosine kinase inhibitors or immune-checkpoint inhibitors) are the most common classes of agents to cause DILI in the Western world. DILI is a diagnosis of exclusion, and thus, careful assessment for other etiologies of liver disease should be undertaken before establishing a diagnosis of DILI. Model for end-stage liver.
  4. Drug-Induced Liver Injury: An Overview. US Pharm. 2016;41 (12):30-34. ABSTRACT: Drug-induced liver injury (DILI) is an uncommon, but potentially fatal, cause of liver disease that is associated with prescription medications, OTC drugs, and herbal and dietary supplements (HDS). DILI has two types: intrinsic and idiosyncratic
  5. ACG Guidelines Monographs Competencies in Endoscopy Consensus Statements Guidelines in Progress Sort A to Z Sort by Date Achalasia - Guideline. September 2020 Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. May 2021. Colleen R. Kelly, MD, AGAF, FACG Idiosyncratic Drug-Induced Liver Injury - Guideline. May.
  6. The European Association for the Study of the Liver (EASL) has released clinical practice guidelines for drug-induced liver injury. Idiosyncratic (unpredictable) drug-induced liver injury is one of the most challenging liver disorders faced by hepatologists, because of the myriad of drugs used in clinical practice, available herbs and dietary supplements with hepatotoxic potential, the ability.
  7. ophen

Drug induced hepatitis is inflammation of the liver caused by drugs (recreational, doctor prescribed or homeopathic). Swelling and pain on the liver area with nausea and jaundice are the main signs, and, beside the great discomfort caused by them, treating this form of hepatitis is important because it can easily lead to cirrhosis or even liver cancer Drug-induced hepatitis is a redness and swelling (inflammation) of the liver. It is a rare condition caused by harmful (toxic) amounts of certain medicines, vitamins, herbal remedies, or food supplements. In most cases, you may be taking a medicine for several months before it reaches a toxic level and affects your liver The focus of these guidelines is idiosyncratic drug-induced liver injury (DILI). However, it is important to recognise that DILI is traditionally classified as intrinsic (or direct) vs. idiosyncratic. Intrinsic DILI is typically dose-related and occurs in a large proportion of individuals exposed to the drug (predictable) and onset is within a short time span (hours to days) In contrast, all the patients in Group B had symptomatic hepatitis (75% icteric hepatitis). There was a mortality rate of 16.6% (four patients). Of the 41 patients from Groups A and B who survived, reintroduction was successful in 38/39 (97.4%)

Tuberculosis treatment in patients with preexisting advanced liver disease poses significant challenges. The likelihood of drug-induced hepatitis is increased with prior advanced liver disease [364], liver transplant [365], or hepatitis C infection [366, 367] Treatment of tuberculosis in patients with liver disease poses various clinical problems. First of all there is an increased risk of drug induced hepatitis in these patients. Besides that, implications of drug-induced hepatitis in this group of patients are potentially more serious as their hepatic reserve is already depleted CSH guidelines for the diagnosis and treatment of drug . Drugs (1 days ago) Drug-induced liver injury (DILI) is an important clinical problem, which has received more attention in recent decades. It can be induced by small chemical molecules, biological agents, traditional Chinese medicines (TCM), natural medicines (NM), health products (HP), and dietary supplements (DS) Reddy KR, Beavers KL, Hammond SP, et al. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology 2015; 148:215. European Association For The Study Of The Liver

Similarly, in drug-induced hepatitis with allergic features, with no improvement after drug withdrawal, a short course of steroids may be justifiable.39 Antioxidants have also been proposed as a treatment modality for severe DILI, and N-acetylcysteine (NAC) is the treatment of choice for paracetamol overdose.7 The role of NAC in non-paracetamol. initial treatment phase also requires deliberation. More recently, a number of fatal cases of drug-induced hepatitis have been reported during the course of treatment of latent TB infection (LTBI) since the publication of the guidelines for the treatment of LTBI by ATS/CDC.14 Although th The principle of therapy for chronic inflammatory liver diseases is the removal of causal agents. For autoimmune liver diseases, however, total removal of causal agents and immune cells is impossible In addition, the liver biopsy may guide therapy, for example, the finding of drug-induced autoimmune hepatitis may call for treatment with steroids. Above all, a liver biopsy helps to rule out competing causes of liver injury, an essential component in the diagnosis of DILI Currently approved clinical interventions for chronic hepatitis B (CHB) are limited to treatments that require long-term therapy for the majority of patients. Although observational studies have shown that sustained HBV DNA suppression achieved with current therapies is associated with improvement in clinical outcomes, an excess risk of hepatocellular carcinoma (HCC) remains,1 and hepatitis B.

Updated March 31, 2020 ~v20_1. Page 3 of 6. SECTION III - HEPATITIS (Including hepatitis A, B and C, autoimmune or drug-induced hepatitis, any other infectious liver disease and chronic liver disease without cirrhosis Abstract. Objective: Many drugs such as minocycline, nitrofurantoin, halothane, non-steroidal anti-inflammatory drugs, anti TNF (Tumor Necrosis Factor) antagonists can induce the autoimmune hepatitis. Herein, we aimed to assess patients suffering from drug induced autoimmune hepatitis who were hospitalized with acute hepatitis like transaminase elevations to our clinic between 2009-2015 Drug-induced hepatitis, the most serious common adverse effect, is defined as a serum AST level more than three times the upper limit of normal in the presence of symptoms, or more than five times the upper limit of normal in the absence of symptoms. The most recent version of guidelines for the treatment of tuberculosis was published in.

Medicine by Sfakianakis G

LATENT TUBERCULOSIS INFECTION (LTBI) TREATMENT GUIDANCE IN WASHINGTON STATE: VERSION 4 December 2020 5 . Daily ISONIAZID . Completion rates of daily INH for 6 - 9 months are significantly lower than 4 months of daily rifampin, 3HP or 3HR. Furthermore, the incidence of drug -induced hepatitis is higher with INH compare For example, halothane can cause necrosis of zone 3 of the acinus and at the same time a picture similar to acute hepatitis. The reaction to derivatives promazina consists of hepatitis and cholestasis. Methyldopa can cause acute or chronic hepatitis, cirrhosis, liver granulomatosis or cholestasis. , , ,

Treatment can relieve symptoms and prevent or reverse liver damage in many people with autoimmune hepatitis. Early treatment of autoimmune hepatitis can lower the chances of developing cirrhosis and other complications. A minority of people who have no symptoms or only a mild form of the disease may or may not need medicines Prednisone alone or a lower dose of prednisone in combination with azathioprine induces remission and enhances survival in autoimmune hepatitis. Treatment failure, incomplete response, drug-induced side effects, and relapse after drug withdrawal are unsatisfactory outcomes that justify the search for new therapies. Potent new drugs promise greater blanket immunosuppression than current.

Hepatitis D is only found in people who are also infected with hepatitis B. Hepatitis E is predominantly found in Africa, Asia and South America. Certain generally safe medications can be toxic to the liver and cause hepatitis (drug-induced hepatitis) when taken in excess or in very high doses Reddy KR, Beavers KL, Hammond SP, Lim JK, Falck-Ytter YT, American Gastroenterological Association I. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology. 2015;148(1):215-219; quiz e216-217

Toxic hepatitis - Diagnosis and treatment - Mayo Clini

The patient diagnosed with metastatic osteosarcoma was given high dose methotrexate treatment, and favipiravir was started on the third day of the treatment with suspicion of SARS-CoV2 infection. Grade 3 hepatotoxicity developed after favipiravir. Management & outcome: The acute viral hepatitis panel and autoimmune liver disease panel were. Corticosteroids are first-line treatment for immune thrombocytopenic purpura. C 2, 21 Treatment is rarely indicated in patients with platelet counts greater than 50 × 10. 3. per µL (50 × 10. 9. Hepatitis C increases your risk of inflammation, damage to your liver, and liver cancer. During and after treatment for the hepatitis C virus (HCV), your doctor may recommend dietary and lifestyle. Individualized genetic factors contribute to disease susceptibility and severity [1,2], drug tolerance [], and drug-induced liver injury (DILI) [].Some genetic loci are potentially translatable to clinical use, for example, the prediction of treatment responsiveness in hepatitis C infection [], severe adverse events caused by the viral replication inhibitor abacavir in HIV treatment [], and. In the 7th edition of the HCV treatment guidelines , DAAs are mentioned as first-choice drugs that are essential for the treatment of hepatitis C. Although treatment with IFN has shown adverse effects in almost all patients, treatment with DAAs has few adverse effects and the response to treatment is also good as indicated above

UpToDat

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in developed countries. Its frequency is increasing in the general population mostly due to the widespread occurrence of obesity and the metabolic syndrome. Although drugs and dietary supplements are viewed as a major cause of acute liver injury, drug induced steatosis and steatohepatitis are considered a rare form of. The ACG guidelines recommend obtaining ultrasonography of the liver and biliary tree in all patients with suspected drug-induced cholestasis, plus an antimitochondrial antibody titer if. Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for oncology, leading to durable remissions in a subset of patients, but also a broad range of potentially life-threatening inflammatory toxicities, many of which involve the gastrointestinal (GI) tract and liver. The purpose of this expert review was to update gastroenterologists on the gastrointestinal and hepatic. Drug-induced hepatotoxicity is an acute or chronic liver injury secondary to drugs or herbal compounds. It is difficult to diagnose because the presentation is similar to many hepatobiliary disorders. The principle treatment is the removal of the offending agent and close observation for resolution. This activity explains the pathophysiology. The only specific treatment for most cases of liver damage caused by taking a drug is to stop the drug that caused the problem. However, if you took high doses of acetaminophen, treatment should be started as soon as possible after you develop hepatitis.. You should rest during the first phase of drug-induced hepatitis, when the symptoms are most severe

For example, halothane can cause necrosis of zone 3 of the acinus and at the same time a picture similar to acute hepatitis. The reaction to derivatives promazina consists of hepatitis and cholestasis. Methyldopa can cause acute or chronic hepatitis, cirrhosis, liver granulomatosis or cholestasis. , , , The AASLD guidelines suggest 2 potential initial treatment regimens for adults (see Table 3, below). Recently, the British Society of Gastroenterology (BSG) has put forth their recommendations on treatment of autoimmune hepatitis. Essentially, the recommendations of both AASLD and BSG are the same and the differences are only in the wording

Drug-induced liver injury from antituberculous treatment

TREATMENT Corticosteroids are often given when all else fails to produce results. Early trials of corticosteroid treatments demonstrated limited benefits. Corticosteroids can be used to treat drug-induced cholestatic hepatitis, in particular associated with hypersensitivity features such as eosinophilia, rash and fever (antiepileptic drugs) Clinical risk factors for drug-induced hepatotoxicity during treatment of tuberculosis include old age, extensive tuberculosis disease, malnutrition, alcoholism, chronic viral hepatitis B and C infections, and HIV infection. One recently published prospective cohort study from Spain6 has shown the incidence o Another type of autoimmune hepatitis is drug induced. If you are suspicious of drug-induced disease, the first thing is to remove the offending medication, Butcher said. In some patients. Drug-induced hepatitis is a redness and swelling (inflammation) of the liver that is caused by a harmful (toxic) amount of certain medicines Tajiri K, Shimizu Y (2008) Practical guidelines for diagnosis and early management of drug-induced liver injury [Internet]. World J. Gastroenterol. Baishideng Publishing Group Co 6774-6785. Link: https://bit.ly/3fDpMIC; Maria VAJ, Victorino RMM (1997) Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis

Some drugs can cause hepatitis with small doses, even if the liver breakdown system is normal. Large doses of many medicines can damage a normal liver. Many different drugs can cause drug-induced hepatitis. Painkillers and fever reducers that contain acetaminophen are a common cause of liver inflammation The association between drug-induced hepatitis and sex is controversial. The present study showed no association between sex and drug-induced hepatitis. A few studies showed that female patients were more vulnerable to drug-induced hepatitis 2, 3, 5, 7, 15, while some showed no sex difference 4, 11, 13, 22 Drug-induced liver injury (DILI) is an adverse reaction to drugs or other xenobiotics that occurs either as a predictable event when an individual is exposed to toxic doses of some compounds or as. The clinical presentation of autoimmune hepatitis varies from asymptomatic to acute liver failure. Symptoms of anorexia, arthralgias, maculopapular rash, and fatigue are typical but not always present. 1 Most patients will have an insidious onset with constitutional symptoms, 16 25% of patients will be asymptomatic and diagnosed incidentally, 1 and 30% of patients will have acute hepatitis.

Drug-induced hepatitis following use of octreotide for

Although AIH diagnosis was not supported by the liver histology, and the scoring for AIH of the International Autoimmune Hepatitis Group was below 10 (probable diagnosis for scores 10-15; and definitive diagnosis for scores > 15) [], with a low dose of prednisolone, patient improved and remained asymptomatic, proving to be beneficial and allowing tuberculosis treatment The effectiveness of the medicine- Convaren for restoration of bile-forming function of liver was studied in comparison with Celagrip, Lesbokhol, Liv.52, and Silibor on tetracycline induced acute hepatitis model. Experimental studies were conducted on white male rats with an initial body weight of 170-200 g. The drug lesion was reproduced by daily oral administration of tetracycline at a dose. Homeopathy provides a very effective and safe treatment for Hepatitis and other liver disorders. It relieves the discoloration of the skin, mucous membrane, and sclera. These medicines strengthen. The risk of anti-tuberculosis (TB) drug-induced liver injury (DILI) in patients with chronic viral hepatitis (CVH) is not clear. The aim of this study was to investigate incidence and risk factors associated with TB DILI in CVH and non-CVH patients. Retrospectively, a total of 128 CVH patients who received anti-TB medication from January 2005 to February 2014 were reviewed

Safety of 3 Different Reintroduction Regimens of

A previous study indicated that 5.1% of patients living with HIV had reactions to Anti-tuberculosis drugs requiring modification of treatment. 12 Drug-induced hepatotoxicity may occur with all currently recommended regimens for the treatment of LTBI 13 and is the commonest of all adverse effects leading to drug discontinuation in 11% of. BackgroundThe country of Georgia has a high prevalence of tuberculosis (TB) and hepatitis C virus (HCV) infection. PurposeTo determine whether HCV co-infection increases the risk of incident drug-induced hepatitis among patients on first-line anti-TB drug therapy. MethodsProspective cohort study; HCV serology was obtained on all study subjects at the time of TB diagnosis; hepatic enzyme tests. Acute hepatitis C may improve or resolve without treatment. It leads to chronic infection in 75 to 85 percent of cases. The chronic form may cause long-term problems in your liver, including liver. Acute vs. Chronic Hepatitis B. A hepatitis B infection can result in either an acute infection or a chronic infection. When a person is first infected with the hepatitis B virus, it is called an acute infection (or a new infection).Most healthy adults that are infected do not have any symptoms and are able to get rid of the virus without any problems Background/Aims: Antituberculosis drug-induced liver injury (TB DILI) is a frequent medical problem in Pakistan. Critical understanding of various aspects of TB DILI is not only important to manage liver injury but may also prevent unnecessary discontinuation of antituberculosis treatment. The study is aimed to determine the frequency, types, severity and patterns of TB DILI

Treatment of TB in Patients With Drug-Induced Hepatiti

New guidelines from the American College of Gastroenterology on idiosyncratic drug-induced liver injury (DILI) emphasize that idiosyncratic DILI is increasingly driven by the burgeoning popularity of herbal and dietary supplements, as well as tyrosine kinase inhibitors and immune checkpoint inhibitors used to treat cancer The treatment by interferon lasted six months to a year, and cured only 40 to 50 percent of hepatitis C patients. The painful injections often made patients feel ill with flu-like symptoms

An Official ATS Statement: Hepatotoxicity of

Drug-induced liver injury: MedlinePlus Medical Encyclopedi